£49.32

It has never been this cheap. We have no record of a lower price.

£49 today · cheaper than every other day in the last 3 months

MDPI AG Treatment Strategies and Survival Outcomes in Breast Cancer

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 56 days · 56 data points (no recent data)

Historical
Generating forecast…
£49.32 £46.85 £47.84 £48.83 £49.81 £50.80 £51.79 23 July 2026 05 August 2026 19 August 2026 02 September 2026 16 September 2026
View at Amazon ↗

Price data last checked 35 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 56 days • 1 price levels

Days at Price
56 days 0 14 28 42 56 £49 Days at Price

Price Analysis

Most common price: £49 (56 days, 100.0%)

Price range: £49 - £49

Price levels: 1 different prices over 56 days

Description

Treatment strategies for breast cancer are wide-ranging and often based on a multi-modality approach, depending on the stage and biology of the tumour and the acceptance and tolerance of the patient. They may include surgery, radiotherapy, and systemic therapy (endocrine therapy, chemotherapy, and targeted therapy). Advances in technologies such as oncoplastic surgery, radiation planning and delivery, and genomics, and the development of novel systemic therapy agents alongside their evaluation in ongoing clinical trials continue to strive for improvements in outcomes. In this Special Issue, we publish a collection of studies looking at all forms of therapeutic strategies for early and advanced breast cancer, focusing on their outcomes, notably survival.

Product Specifications

Brand
MDPI AG
Format
hardcover
Domain
Amazon UK
Release Date
30 April 2020
Listed Since
09 May 2020

Barcode

No barcode data available

Similar Products You Might Like

Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)
84% match

Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)

Springer

£103.27 08 Aug 2026
Prognostic variables in node-negative and node-positive breast cancer
83% match

Prognostic variables in node-negative and node-positive breast cancer

Springer

£153.04 05 Aug 2026
Sequential therapy in metastatic breast cancer patients: Survival analysis with time dependent covariates
83% match

Sequential therapy in metastatic breast cancer patients: Survival analysis with time dependent covariates

VDM Verlag

£41.00 16 Sep 2026
Breast Cancer: Nuclear Medicine in Diagnosis and Therapeutic Options
83% match

Breast Cancer: Nuclear Medicine in Diagnosis and Therapeutic Options

Springer

£60.45 08 Aug 2026
A Practical Guide to Breast Cancer Treatment
83% match

A Practical Guide to Breast Cancer Treatment

Springer

£115.72 04 Aug 2026
Breast Cancer (MD Anderson Solid Tumor Oncology Series)
83% match

Breast Cancer (MD Anderson Solid Tumor Oncology Series)

Springer

£78.01 13 Aug 2026
Breast Cancer Management for Surgeons: A European Multidisciplinary Textbook
83% match

Breast Cancer Management for Surgeons: A European Multidisciplinary Textbook

Springer

£156.70 05 Aug 2026
Adjuvant Therapy of Breast Cancer V: 140 (Recent Results in Cancer Research, 140)
83% match

Adjuvant Therapy of Breast Cancer V: 140 (Recent Results in Cancer Research, 140)

Springer

£76.42 18 Aug 2026
Breast Cancer Chemosensitivity: 608 (Advances in Experimental Medicine and Biology, 608)
83% match

Breast Cancer Chemosensitivity: 608 (Advances in Experimental Medicine and Biology, 608)

Springer

£92.50 14 Sep 2026
Breast Cancer: Evolving Challenges and Next Frontiers
82% match

Breast Cancer: Evolving Challenges and Next Frontiers

IntechOpen

£119.00 29 Aug 2026
Breast Cancer, An Issue of Hematology/Oncology Clinics of North America (Volume 27-4) (The Clinics: Internal Medicine, Volume 27-4)
82% match

Breast Cancer, An Issue of Hematology/Oncology Clinics of North America (Volume 27-4) (The Clinics: Internal Medicine, Volume 27-4)

Elsevier

£55.49 04 Aug 2026
Management of Breast Diseases
82% match

Management of Breast Diseases

Springer

£104.99 14 Sep 2026
Improving Outcomes for Breast Cancer Survivors: Perspectives on Research Challenges and Opportunities: 862 (Advances in Experimental Medicine and Biology, 862)
82% match

Improving Outcomes for Breast Cancer Survivors: Perspectives on Research Challenges and Opportunities: 862 (Advances in Experimental Medicine and Biology, 862)

Springer

£78.95 06 Aug 2026
Changing Paradigms in the Management of Breast Cancer
82% match

Changing Paradigms in the Management of Breast Cancer

Springer

£80.67 14 Sep 2026
Breast Cancer Metastasis and Drug Resistance: Progress and Prospects
82% match

Breast Cancer Metastasis and Drug Resistance: Progress and Prospects

Springer

£125.82 15 Sep 2026
Adjuvant Therapy of Breast Cancer: 60 (Cancer Treatment and Research, 60)
82% match

Adjuvant Therapy of Breast Cancer: 60 (Cancer Treatment and Research, 60)

Springer

£148.28 05 Aug 2026
Short Course Breast Radiotherapy: A Comprehensive Review of Hypofractionation, Partial Breast, and Intra-Operative Irradiation
81% match

Short Course Breast Radiotherapy: A Comprehensive Review of Hypofractionation, Partial Breast, and Intra-Operative Irradiation

Springer

£115.43 14 Sep 2026
Advances in the Treatment of Renal Cell Carcinoma
81% match

Advances in the Treatment of Renal Cell Carcinoma

£41.90 14 Sep 2026
Resistance to Targeted Therapies in Breast Cancer: 16 (Resistance to Targeted Anti-Cancer Therapeutics, 16)
81% match

Resistance to Targeted Therapies in Breast Cancer: 16 (Resistance to Targeted Anti-Cancer Therapeutics, 16)

Springer

£80.65 06 Aug 2026
Omics Approaches in Breast Cancer: Towards Next-Generation Diagnosis, Prognosis and Therapy
81% match

Omics Approaches in Breast Cancer: Towards Next-Generation Diagnosis, Prognosis and Therapy

Springer

£74.21 08 Aug 2026
Advances in Cancer Therapy from Research to Clinical Practice: Surgical, Molecular or Systemic Management of Cancer
81% match

Advances in Cancer Therapy from Research to Clinical Practice: Surgical, Molecular or Systemic Management of Cancer

£64.26 14 Sep 2026
Endocrine Therapy of Breast Cancer VI (ESO Monographs)
81% match

Endocrine Therapy of Breast Cancer VI (ESO Monographs)

Springer

£76.42 07 Aug 2026
Signaling Pathways in Breast Cancer: Molecular Mechanisms, Therapeutic Strategies, and Multidrug Resistance
81% match

Signaling Pathways in Breast Cancer: Molecular Mechanisms, Therapeutic Strategies, and Multidrug Resistance

Elsevier

£145.99 04 Aug 2026
Breast Cancer Risk Reduction and Early Detection
81% match

Breast Cancer Risk Reduction and Early Detection

Springer

£79.70 08 Aug 2026